Summary
Overview
Dr. Joanna Moncrieff challenges the widespread belief that depression is caused by a chemical imbalance, revealing how pharmaceutical companies promoted this unproven theory to sell antidepressants. With nearly one in five adults in England taking these medications, she argues that we've medicalized normal human responses to difficult circumstances, overlooking the lack of evidence for biological causes while ignoring potentially serious side effects and withdrawal problems. The conversation explores the commercial interests behind psychiatric drug promotion, the dangers of viewing depression as a fixed medical condition, and the importance of understanding what these drugs actually do to our brains.
The Chemical Imbalance Theory: Debunking a Medical Myth
Dr. Moncrieff explains how depression was historically understood as an understandable reaction to difficult life circumstances until the 1990s, when pharmaceutical companies promoting SSRIs popularized the idea that depression stems from a brain chemical imbalance. Her 2022 systematic review of thousands of studies found no consistent evidence that people with depression have abnormal serotonin levels. Despite this lack of evidence, the theory persists on medical websites and in public consciousness, having been so thoroughly established by pharmaceutical marketing campaigns.
- Depression was traditionally seen as an understandable reaction to bad circumstances like unemployment, divorce, or childhood trauma, with natural variations between individuals
- In the 1990s, pharmaceutical companies promoted the idea that depression is caused by a serotonin deficiency to distinguish new SSRIs from problematic benzodiazepines
- A 2022 systematic review found no consistent evidence of serotonin abnormalities in people with depression - some studies showed lower levels, some higher, some no difference
- The serotonin theory was originally proposed in the 1960s but wasn't widely accepted until pharmaceutical industry promotional campaigns in the 1990s
" There is no evidence that you have a chemical imbalance in your brain if you are depressed. So therefore there's no evidence that that antidepressant you're being offered is going to correct that. "
" They haven't asked that question about what antidepressants might be doing by just messing about with our normal brain chemistry. "
The Scale of Antidepressant Use and What SSRIs Actually Do
The statistics are staggering: 8.7 million people in England alone take antidepressants, representing nearly one in five adults. SSRIs work by inhibiting the protein that removes serotonin from nerve synapses, theoretically enhancing serotonin activity. However, the evidence for what they actually do is murky - they may temporarily increase serotonin but long-term use might actually lower it. The only consistent evidence for serotonin's role in human functioning is its negative impact on sexual function.
- Approximately 8.7 million people in England take antidepressants, which is 15-17% of the adult population
- SSRIs inhibit the protein that removes serotonin from the space between nerve cells, theoretically enhancing its activity
- Some evidence suggests long-term antidepressant use may actually result in lower serotonin activity rather than higher
- The only area with consistent evidence of serotonin's effects is sexual functioning - higher serotonin reduces sexual desire and function
" Almost one out of five are taking antidepressants, which is absolutely staggering, isn't it? "
📚 7 more sections below
Sign up to unlock the complete summary with all insights, key points, and quotes
Get this summary + all future TRIGGERnometry episodes in your inbox
100% Free • Unsubscribe Anytime
Sign up now and we'll send you the complete summary of this episode, plus get notified when new TRIGGERnometry episodes are released—delivered straight to your inbox within minutes.